Transplant Diagnostics Market: Current Analysis and Forecast (2021 - 2027)

Transplant Diagnostics Market: Current Analysis and Forecast (2021 - 2027)

  • UnivDatos Market Insight
  • July 2021
  • Healthcare
  • 162 pages

Report Description

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after a transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, and technological advancements in the field of transplant diagnostics.

The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. The gap between the demand and supply of organs as demand is always higher than the supply accelerates the transplant diagnostics market growth.

Factors such as reimbursement conflicts and ethical issues in some regions of the world are projected to limit market expansion. Furthermore, the high cost of completing HLA matching utilizing Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) technologies is impeding the development of the transplant diagnostics market in underdeveloped nations.

Based on technology, the market is fragmented into molecular assay technologies, PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. Molecular assay technologies are further categized as PCR-based and sequencing-based molecular assays. The molecular assay technology segment generated revenue of USD XX billion in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.

Based on products & services, the market is fragmented into reagents & consumables, instruments, software & services. The instruments segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the increasing healthcare expenditures.

Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, bone marrow transplantation. The solid organ transplantation segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the application, the market is fragmented to diagnostic applications and research applications. The diagnostic applications segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX million by the year 2027F on account of its varied applications in patient profilin and increasing clinical evidence of its efficacy, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the end-user, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F on account of the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, growing at a CAGR of XX% over the forecast period (2021-2027).

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Transplant Diagnostics industry and generated revenue of USD XX billion in 2020 and would grow at a CAGR of XX%, owing to the presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, and the large volume of organ transplantation procedures performed in the region.

Some of the major players operating in the market include TE Connectivity, HARTING, HIROSE, Würth Electronics, Phoenix Contact, Softing AG, Belden, LEONI, MURR Elektronik, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing number of organ transplant, and technological advancements in the field of transplant diagnostics. In 2019, the rate of patients having transplanted organs in several nations around the world. During this year, France had a rate of roughly 87 organ transplant patients per million inhabitants. If blood and oxygen are flowing through the organs until the moment of recovery, organ donation can be done by both a deceased and a living donor. The increased rate of organ transplantation is due to the increase in diseases causing severe organ damages. This has been boosting the demand for diagnostic transplants.

Although there are more than 107,453 waiting for organ transplants, there has been a steady rise in the number of donor rates, followed by the deceased donor rate.  For instance, as per Global Observatory on Donation and Transplantation (GODT), number of live kidney donors increased by 3.3%b whereas number of deceased donors increased by 8.1% from 2018 to 2019. This shows the improvement and demand for more diagnostics facilities across the healthcare sector related to transplant. The increase in number of organ donors is expected to be very lucrative for growth and dominance of transplant over the forecast period.

In the last decade, healthcare spending in those countries has remained about in line with total economic growth. Between 2010 and 2019, health spending in the OECD averaged around 8.7% of GDP every year. In the same time span, however, healthcare spending in the United States increased from 16.3 percent to 17.0 percent of GDP. 

As per OECD data of 2019, the United States accounted for highest per capita GDP of 17% followed by Switzerland and Germany with GDP of 12.1% and 11.7%, respectively. The improvement in healthcare is expected to boost the market for Transplant Diagnostics Market.

Bio-Rad laboratories, Inc., Dorel Industries Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc., bioMérieux S.A., Immucor, Inc., llumina, Inc., Luminex Corporation, Becton, Dickinson and Company, are some of the prominent players operating in the global Transplant Diagnostics market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst Technology, Molecular Assay Technologies segment holds the major share”

Based on technology, the market is fragmented into molecular assay technologies, and non-molecular assay technologies. Further, the molecular technologies studied into PCR-based molecular assays, sequencing based molecular assays. The molecular assay technologies segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.

“Amongst Product & Service, Instruments is anticipated to grow at the highest CAGR during the analyzed period”

Further based on product & service, the market is fragmented into reagents & consumables, instruments, software & services. In 2020, instruments accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the increasing healthcare expenditures.

Amongst Transplant Type, Solid Organ Transplantation segment holds the major share”

Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.

Amongst Application, Diagnostic Application segment holds the major share”

Based on the application, the market is fragmented into diagnostic applications and research applications. The diagnostic applications centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period on account of its varied applications in patient profiling and increasing clinical evidence of its efficacy.

Amongst End-User, Independent Reference Laboratories segment holds the major share”

Based on the end-user type, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period owing to the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

“North America signifies one of the largest markets of Transplant Diagnostics Market”

For a better understanding of the market dynamics of the Transplant Diagnostics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth. Although there are 107,453 of individuals are in the waiting list waiting list in USA but at the same time the number of donors are also increasing at a good pace.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Transplant Diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Companies Covered

  • Bio-Rad laboratories Inc.
  • Dorel Industries Inc.
  • F. Hoffman-La Roche Ltd.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • bioMérieux S.A.
  • Immucor Inc.
  • llumina, Inc.
  • Luminex Corporation
  • Becton
  • Dickinson
  • Company

Have query on this report?

Make an Enquiry

Table of Content

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Transplant Diagnostics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Transplant Diagnostics Market
2.1.1 Main Objective of the Global Transplant Diagnostics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER TRANSPLANT DIAGNOSTICS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET REVENUE

8 MARKET INSIGHTS BY TECHNOLOGY

8.1 Molecular Assay Technologies
8.1.1 PCR-based molecular assays
8.1.2 Sequencing Based Molecular Assays
8.2 Non-molecular Assays Technology

9 MARKET INSIGHTS BY PRODUCT & SERVICES
9.1 Reagents & Consumables
9.2 Instruments
9.3 Software & Services

10 MARKET INSIGHTS BY TRANSPLANT TYPE
10.1 Solid organ transplantation
10.2 Stem cell transplantation
10.3 Soft tissue transplantation
10.4 Bone marrow transplantation

11 MARKET INSIGHTS BY Application
11.1 Diagnostic application
11.1.1 Pre transplantation diagnostics
11.1.2 Post transplantation diagnostics
11.2 Research Application

12 MARKET INSIGHTS BY End-user
12.1 Independent reference laboratories
12.2 Hospitals & transplants ceneters
12.3 Research laboratories & Academic institutes

13 MARKET INSIGHTS BY REGION
13.1 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET
13.1.1 United States
13.1.2 Canada
13.1.3 Rest of North America
13.2 EUROPE TRANSPLANT DIAGNOSTICS MARKET
13.2.1 Germany
13.2.2 France
13.2.3 United Kingdom
13.2.4 Spain
13.2.5 Italy
13.2.6 Rest of Europe
13.3 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET
13.3.1 China
13.3.2 Japan
13.3.3 India
13.3.4 Australia
13.3.5 South Korea
13.3.6 Rest of Asia Pacific
13.4 REST OF THE WORLD TRANSPLANT DIAGNOSTICS MARKET

14 BABY MONITOR MARKET DYNAMICS
14.1 Market Drivers
14.2 Market Challenges
14.3 Impact Analysis

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1 Demand Side Analysis
16.2 Supply Side Analysis
16.2.1 Top Product Launches
16.2.2 Top Business Partnerships
16.2.3 Top Merger & Acquisitions

17 VALUE CHAIN ANALYSIS

18 TRANSPLANT DIAGNOSTICS MARKET OPPORTUNITIES

19 TRANSPLANT DIAGNOSTICS MARKET TRENDS & INSIGHTS

20 COMPETITIVE SCENARIO

20.1 Porter’s Five forces analysis
20.1.1 Bargaining power of Supplier
20.1.2 Bargaining power of Buyer
20.1.3 Industry Rivalry
20.1.4 Availability of Substitute
20.1.5 Threat of new Entrants

21 COMPANY PROFILED
21.1 Bio-Rad laboratories, Inc.
21.1.1 Key Facts
21.1.2 Business Description
21.1.3 Key Product/Services Offerings
21.1.4 Growth Strategy
21.1.5 SWOT Analysis
21.1.6 Key Financials
21.1.6.1 Revenue Split
21.1.6.2 Financial Overview of Bio-Rad laboratories, Inc.
21.1.7 Recent Developments
21.1.7.1 Product Launch
21.1.7.2 Partnerships
21.1.7.3 Business Expansion and Investments
21.1.7.4 Merger and Acquisition
21.2 Dorel Industries Inc.
21.3 F. Hoffman-La Roche Ltd.
21.4 QIAGEN N.V.
21.5 Thermo Fisher Scientific Inc.
21.6 bioMérieux S.A.
21.7 Immucor, Inc.
21.8 llumina, Inc.
21.9 Luminex Corporation
21.10 Becton, Dickinson and Company

22 DISCLAIMER

Success Stories

Our Clients